- Home
- DBVT vs ZTEK Comparison
DBVT vs ZTEK Comparison
Compare DBVT & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- ZTEK
- Stock Information
- Founded
- DBVT 2002
- ZTEK 2008
- Country
- DBVT France
- ZTEK Canada
- Employees
- DBVT N/A
- ZTEK N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- ZTEK Major Chemicals
- Sector
- DBVT Health Care
- ZTEK Industrials
- Exchange
- DBVT Nasdaq
- ZTEK Nasdaq
- Market Cap
- DBVT 102.0M
- ZTEK 122.0M
- IPO Year
- DBVT N/A
- ZTEK N/A
- Fundamental
- Price
- DBVT $4.40
- ZTEK $1.02
- Analyst Decision
- DBVT Strong Buy
- ZTEK
- Analyst Count
- DBVT 2
- ZTEK 0
- Target Price
- DBVT $22.50
- ZTEK N/A
- AVG Volume (30 Days)
- DBVT 28.3K
- ZTEK 35.9K
- Earning Date
- DBVT 03-06-2025
- ZTEK 03-04-2025
- Dividend Yield
- DBVT N/A
- ZTEK N/A
- EPS Growth
- DBVT N/A
- ZTEK N/A
- EPS
- DBVT N/A
- ZTEK N/A
- Revenue
- DBVT $12,515,000.00
- ZTEK $44,936.00
- Revenue This Year
- DBVT N/A
- ZTEK N/A
- Revenue Next Year
- DBVT $2,860.00
- ZTEK N/A
- P/E Ratio
- DBVT N/A
- ZTEK N/A
- Revenue Growth
- DBVT 125.54
- ZTEK 92.38
- 52 Week Low
- DBVT $0.44
- ZTEK $0.50
- 52 Week High
- DBVT $5.42
- ZTEK $1.34
- Technical
- Relative Strength Index (RSI)
- DBVT 54.39
- ZTEK 42.80
- Support Level
- DBVT $4.18
- ZTEK $1.02
- Resistance Level
- DBVT $4.47
- ZTEK $1.20
- Average True Range (ATR)
- DBVT 0.28
- ZTEK 0.08
- MACD
- DBVT -0.04
- ZTEK -0.01
- Stochastic Oscillator
- DBVT 71.34
- ZTEK 18.18
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.